$CMCO Cashflow Statement | Understand Stock

$CMCO

$15.06 +$0.13 (0.87%) Close

$CMCO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2026 12 months to Mar 31, 2026	FY2025 12 months to Mar 31, 2025	FY2024 12 months to Mar 31, 2024	FY2023 12 months to Mar 31, 2023	FY2022 12 months to Mar 31, 2022
Operating activities:
Net income
Net income (loss) attributable to the Company
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Depreciation and amortization
Deferred income taxes and related valuation allowance
Net gain from sale of business
Net loss (gain) on sale of real estate, investments and other
Loss on sales of businesses
Stock-based compensation
Amortization of deferred financing costs
Loss (gain) on hedging instruments
Cost of debt refinancing
Loss on impairment of goodwill
Cost of debt refinancing and repricing
Impairment of operating lease
Loss on disposals and impairments of fixed assets
Non-cash pension settlement expense (See Note 13)
Gain on sale of building (See Note 3)
Non-cash lease expense

Changes in operating assets and liabilities, net of effects of business acquisitions and divestitures:
Trade accounts receivable
Inventories
Prepaid expenses and other
Increase (Decrease) in Other Operating Assets
Other assets
Trade accounts payable
Accrued liabilities
Non-current liabilities

Net cash provided by (used for) operating activities
Investing activities:
Proceeds from sales of marketable securities
Purchases of marketable securities
Capital expenditures
Proceeds from sale of buildings, net of transaction costs
Proceeds from insurance reimbursement
Dividend received from equity method investment
Proceeds from sale of fixed assets
Payments for (Proceeds from) Businesses and Interest in Affiliates
Net proceeds from the sales of businesses
Purchase of businesses, net of cash and restricted cash acquired (See Note 3)
Net cash provided by (used for) investing activities

Financing activities:
Proceeds from (Repayments of) Debt, Maturing in More than Three Months
Repayments of Lines of Credit
Proceeds from issuance of common stock
Proceeds from issuance of preferred stock, net of expenses
Fees paid for debt repricing
Purchases of treasury stock
Repayment of debt
Payments of Financing Costs
Payment to former owners of montratec (see Note 3)
Fees paid for borrowing on long-term debt
Proceeds from issuance of long-term debt
Proceeds from equity offering
Fees related to debt and equity offering
Cash inflows from hedging activities
Cash outflows from hedging activities
Payment of dividends
Other
Net cash provided by (used for) financing activities

Effect of exchange rate changes on cash
Net change in cash and cash equivalents
Cash, cash equivalents, and restricted cash at beginning of year
Cash, cash equivalents, and restricted cash at end of year
Supplementary cash flows data:
Interest paid
Income taxes paid, net of refunds
Property, plant and equipment purchases included in trade accounts payable
Decrease in Restricted Cash
Restricted cash presented in Other assets

Comments